Pharmaceutical

Influenza (quadrivalent) vaccine by Pfizer for Influenzavirus A Infections: Likelihood of Approval

Influenza (quadrivalent) vaccine is under clinical development by Pfizer and currently in Phase III for Influenzavirus A Infections.

May 17, 2024 - 04:00
Influenza (quadrivalent) vaccine is under clinical development by Pfizer and currently in Phase III for Influenzavirus A Infections.
Read the original article

Tags:

Previous Article

Influenza (quadrivalent) vaccine by Pfizer for Influenzavirus B Infections: Like...

Next Article

TT-01488 by TransThera Sciences (Nanjing) for Mantle Cell Lymphoma: Likelihood o...

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

A replacement for race: Medical experts explore how to eliminate bias in clinical algorithms

A replacement for race: Medical experts explore how to ...

Jun 28, 2023

With a rare immunodeficiency disease, a performer and patient advocate learned lessons the hard way

With a rare immunodeficiency disease, a performer and p...

Oct 10, 2023

Vertex licenses Editas’ gene editing technology in $100m deal

Vertex licenses Editas’ gene editing technology in $100...

Dec 14, 2023